INCRELEX

This brand name is authorized in Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, UK, United States.

Active ingredients

The drug INCRELEX contains one active pharmaceutical ingredient (API):

1	Mecasermin UNII 7GR9I2683O - MECASERMIN
	Mecasermin is a human insulin-like growth factor-1 (rhIGF-1) produced by recombinant DNA technology. Insulin-like growth factor-1 (IGF-1) is the principal hormonal mediator of statural growth. Mecasermin is indicated for the long-term treatment of growth failure in patients with confirmed severe primary insulin-like growth factor-1 deficiency (Primary IGFD).
	Read more about Mecasermin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INCRELEX Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AC03	Mecasermin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	130-MBE-0818
EE	Ravimiamet	1305874
FI	Lääkealan turvallisuus- ja kehittämiskeskus	106397
FR	Base de données publique des médicaments	66263258
GB	Medicines & Healthcare Products Regulatory Agency	121015
IE	Health Products Regulatory Authority	88405
IL	מִשְׂרַד הַבְּרִיאוּת	8710
IT	Agenzia del Farmaco	038095016
LT	Valstybinė vaistų kontrolės tarnyba	1028423
NL	Z-Index G-Standaard	15255042
NL	Z-Index G-Standaard, PRK	85464
PL	Rejestru Produktów Leczniczych	100181004
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57400001
US	FDA, National Drug Code	15054-1040